- Report
- March 2026
- 220 Pages
Global
From €4310EUR$4,799USD£3,682GBP
- Report
- October 2025
- 573 Pages
Global
From €6422EUR$7,150USD£5,486GBP
- Report
- April 2026
- 143 Pages
Global
From €2694EUR$2,999USD£2,301GBP
€3592EUR$3,999USD£3,068GBP
- Report
- August 2026
- 184 Pages
Global
From €3184EUR$3,545USD£2,720GBP
€3538EUR$3,939USD£3,022GBP
- Report
- February 2026
- 250 Pages
Global
From €4033EUR$4,490USD£3,445GBP
- Report
- August 2026
- 217 Pages
Global
From €5254EUR$5,850USD£4,488GBP
- Report
- January 2026
- 200 Pages
Global
From €4486EUR$4,995USD£3,832GBP
- Report
- January 2026
- 160 Pages
Global
From €2838EUR$3,160USD£2,424GBP
€3548EUR$3,950USD£3,031GBP
- Report
- January 2026
- 150 Pages
Global
From €4356EUR$4,850USD£3,721GBP
- Report
- August 2025
- 150 Pages
Middle East
From €4446EUR$4,950USD£3,798GBP
- Report
- January 2026
- 280 Pages
Global
From €3245EUR$3,613USD£2,772GBP
€3817EUR$4,250USD£3,261GBP
- Report
- May 2026
- 120 Pages
Global
From €5344EUR$5,950USD£4,565GBP
- Report
- August 2026
- 190 Pages
Global
From €3184EUR$3,545USD£2,720GBP
€3538EUR$3,939USD£3,022GBP
- Report
- February 2026
- 250 Pages
Global
From €4033EUR$4,490USD£3,445GBP
- Report
- September 2025
- 393 Pages
Global
From €5271EUR$6,074USD£4,350GBP
- Report
- June 2026
- 222 Pages
Global
From €4310EUR$4,799USD£3,682GBP
- Report
- June 2026
- 765 Pages
Global
From €4446EUR$4,950USD£3,798GBP
- Report
- October 2025
- 323 Pages
Global
From €4446EUR$4,950USD£3,798GBP
- Report
- February 2026
- 250 Pages
Global
From €4033EUR$4,490USD£3,445GBP
- Report
- October 2025
- 274 Pages
Global
From €4177EUR$4,650USD£3,568GBP

The Single Use Bioprocessing market is a subset of the biotechnology industry that focuses on the development and production of biopharmaceuticals using disposable components. This technology is used to reduce the risk of cross-contamination and simplify the manufacturing process. Single use bioprocessing systems are designed to be used for a single batch of product, and then disposed of. This technology is used in the production of vaccines, monoclonal antibodies, and other biopharmaceuticals.
Single use bioprocessing systems are becoming increasingly popular due to their cost-effectiveness and scalability. This technology is also beneficial for companies that need to quickly scale up production for new products.
Some companies in the Single Use Bioprocessing market include Thermo Fisher Scientific, Merck KGaA, Sartorius AG, Danaher Corporation, and GE Healthcare. Show Less Read more